Hyloris Pharmaceuticals SA
EBR:HYL.BR
Overview | Financials
Company Name | Hyloris Pharmaceuticals SA |
Symbol | HYL.BR |
Currency | EUR |
Price | 5.96 |
Market Cap | 166,882,384 |
Dividend Yield | 0% |
52-week-range | 2.89 - 14.1 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Stijn Van Rompay |
Website | https://hyloris.com |
An error occurred while fetching data.
About Hyloris Pharmaceuticals SA
Hyloris Pharmaceuticals SA engages in the develop, manufacture, and deliver pharmaceutical products to address unmet medical needs in cardiovascular health, oncology, women's health, and other major therapeutic areas. The company offers cardiovascular products for atrial fibrillation, acute coronary syndrome, advanced heart failure, congestive heart failure, acute coronary syndrome, and coronary
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD